Influx Health.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MYZ01012
  • NSEID: INFLUX
  • BSEID:
INR
240.00
-2.05 (-0.85%)
BSENSE

Dec 05

BSE+NSE Vol: 60600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.88%

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 19.23%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 21.23%

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -22.73%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Influx Health. With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
104.85
108.60
-3.75
-3.45%
Other Operating Income
0.00
0.00
0.00
Total Operating income
104.85
108.60
-3.75
-3.45%
Raw Material Cost
63.41
37.38
26.03
69.64%
Purchase of Finished goods
0.00
0.01
-0.01
-100.00%
(Increase) / Decrease In Stocks
0.01
-1.52
1.53
100.66%
Employee Cost
8.79
10.12
-1.33
-13.14%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
12.08
23.39
-11.31
-48.35%
Total Expenditure (Excl Depreciation)
84.29
69.38
14.91
21.49%
Operating Profit (PBDIT) excl Other Income
20.56
39.22
-18.66
-47.58%
Other Income
0.13
3.73
-3.60
-96.51%
Operating Profit (PBDIT)
20.69
42.95
-22.26
-51.83%
Interest
0.17
2.08
-1.91
-91.83%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
20.52
40.87
-20.35
-49.79%
Depreciation
2.82
9.57
-6.75
-70.53%
Profit Before Tax
17.71
31.30
-13.59
-43.42%
Tax
4.44
8.20
-3.76
-45.85%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.27
23.10
-9.83
-42.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.27
23.10
-9.83
-42.55%
Equity Capital
18.15
12.84
5.31
41.36%
Face Value
10.00
10.00
0.00
Reserves
18.00
132.36
-114.36
-86.40%
Earnings per share (EPS)
7.31
17.99
-10.68
-59.37%
Diluted Earnings per share
7.31
17.98
-10.67
-59.34%
Operating Profit Margin (Excl OI)
19.61%
36.11%
0.00
-16.50%
Gross Profit Margin
19.57%
37.63%
0.00
-18.06%
PAT Margin
12.66%
21.27%
0.00
-8.61%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 104.85 Cr
in Mar 2025

Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 13.27 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.56 Cr
in Mar 2025

Figures in Cr
Annual - Interest
Interest 0.17 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.61%
in Mar 2025

Figures in %